Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1959 1
1965 1
1966 1
1972 2
1973 1
1974 1
1975 1
1976 4
1977 1
1978 3
1979 5
1980 1
1981 4
1982 1
1983 5
1984 5
1985 7
1986 4
1987 10
1988 12
1989 12
1990 19
1991 18
1992 19
1993 19
1994 21
1995 23
1996 37
1997 30
1998 37
1999 38
2000 36
2001 47
2002 77
2003 102
2004 123
2005 118
2006 126
2007 140
2008 153
2009 162
2010 174
2011 201
2012 217
2013 299
2014 333
2015 344
2016 376
2017 393
2018 466
2019 543
2020 607
2021 689
2022 527
Text availability
Article attribute
Article type
Publication date

Search Results

5,937 results
Results by year
Filters applied: . Clear all
Page 1
Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms.
Zhu R, Yan T, Feng Y, Liu Y, Cao H, Peng G, Yang Y, Xu Z, Liu J, Hou W, Wang X, Li Z, Deng L, Wang S, Li J, Han Q, Li H, Shan G, Cao Y, An X, Yan J, Zhang Z, Li H, Qu X, Zhu J, Zhou S, Wang J, Zhang F, Gao J, Jin R, Xu D, Ma YQ, Huang T, Peng S, Zheng Z, Stambler I, Gilson E, Lim LW, Moskalev A, Cano A, Chakrabarti S, Ulfhake B, Su H, Xu H, Xu S, Wei F, Brown-Borg HM, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC. Zhu R, et al. Among authors: peng s. Cell Res. 2021 Dec;31(12):1244-1262. doi: 10.1038/s41422-021-00573-y. Epub 2021 Oct 26. Cell Res. 2021. PMID: 34702946 Free PMC article.
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
Brakedal B, Dölle C, Riemer F, Ma Y, Nido GS, Skeie GO, Craven AR, Schwarzlmüller T, Brekke N, Diab J, Sverkeli L, Skjeie V, Varhaug K, Tysnes OB, Peng S, Haugarvoll K, Ziegler M, Grüner R, Eidelberg D, Tzoulis C. Brakedal B, et al. Among authors: peng s. Cell Metab. 2022 Mar 1;34(3):396-407.e6. doi: 10.1016/j.cmet.2022.02.001. Cell Metab. 2022. PMID: 35235774 Free article. Clinical Trial.
Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy.
Peng S, Hu P, Xiao YT, Lu W, Guo D, Hu S, Xie J, Wang M, Yu W, Yang J, Chen H, Zhang X, Zhu Y, Wang Y, Yang Y, Zhu G, Chen S, Wang J, Zhang B, Chen W, Wu H, Sun Z, Ding T, Zhang H, Yi Z, Liu M, Ren S. Peng S, et al. Clin Cancer Res. 2022 Feb 1;28(3):552-567. doi: 10.1158/1078-0432.CCR-21-0299. Epub 2021 Nov 5. Clin Cancer Res. 2022. PMID: 34740924
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma.
Yang W, Xing X, Yeung SJ, Wang S, Chen W, Bao Y, Wang F, Feng S, Peng F, Wang X, Chen S, He M, Zhang N, Wang H, Zeng B, Liu Z, Kidane B, Seder CW, Koyanagi K, Shargall Y, Luo H, Peng S, Cheng C. Yang W, et al. Among authors: peng s. J Immunother Cancer. 2022 Jan;10(1):e003497. doi: 10.1136/jitc-2021-003497. J Immunother Cancer. 2022. PMID: 35022193 Free PMC article.
Decoding the Equine Genome: Lessons from ENCODE.
Peng S, Petersen JL, Bellone RR, Kalbfleisch T, Kingsley NB, Barber AM, Cappelletti E, Giulotto E, Finno CJ. Peng S, et al. Genes (Basel). 2021 Oct 27;12(11):1707. doi: 10.3390/genes12111707. Genes (Basel). 2021. PMID: 34828313 Free PMC article. Review.
5,937 results